| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.82B | 14.71B | 14.00B | 13.13B | 11.89B | 11.55B |
| Gross Profit | 4.95B | 4.52B | 4.46B | 4.41B | 3.75B | 3.73B |
| EBITDA | 1.73B | 1.82B | 1.41B | 1.72B | 977.00M | 1.63B |
| Net Income | 1.33B | 1.28B | 959.00M | 1.21B | 682.00M | 1.18B |
Balance Sheet | ||||||
| Total Assets | 68.56B | 69.44B | 60.81B | 59.56B | 55.79B | 61.69B |
| Cash, Cash Equivalents and Short-Term Investments | 3.42B | 4.13B | 472.00M | 345.00M | 475.00M | 536.00M |
| Total Debt | 2.97B | 2.97B | 3.21B | 3.25B | 3.00B | 3.03B |
| Total Liabilities | 57.70B | 57.82B | 50.30B | 49.67B | 47.25B | 48.88B |
| Stockholders Equity | 10.86B | 11.62B | 10.51B | 9.89B | 8.55B | 12.81B |
Cash Flow | ||||||
| Free Cash Flow | 2.16B | 2.40B | 2.48B | 2.19B | 2.45B | 1.97B |
| Operating Cash Flow | 2.25B | 2.49B | 2.57B | 2.29B | 2.50B | 2.00B |
| Investing Cash Flow | -1.09B | -1.45B | -1.32B | -1.84B | -1.51B | -1.23B |
| Financing Cash Flow | -1.12B | -1.10B | -1.12B | -577.00M | -1.03B | -648.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
85 Outperform | $6.83B | 8.24 | 20.92% | 1.97% | 6.41% | 66.30% | |
80 Outperform | $5.43B | 11.67 | 12.93% | 1.85% | 8.76% | 99.32% | |
76 Outperform | $11.36B | 13.92 | 18.76% | 6.71% | -1.65% | 10.67% | |
73 Outperform | $4.83B | 23.95 | 22.00% | 4.05% | 9.01% | 40.14% | |
68 Neutral | $7.37B | 7.37 | 16.93% | 1.80% | 9.07% | 33.25% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | $11.92B | 9.61 | 11.94% | 8.03% | 4.05% | 35.90% |